Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
69.30
-0.86 (-1.23%)
At close: Mar 28, 2025, 4:00 PM
69.29
-0.01 (-0.01%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Novo Nordisk Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Novo Nordisk stock have an average target of 141.67, with a low estimate of 105 and a high estimate of 160. The average target predicts an increase of 104.43% from the current stock price of 69.30.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 23, 2024.
Analyst Ratings
The average analyst rating for Novo Nordisk stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Sell → Strong Buy Upgrades n/a | Strong Sell → Strong Buy | Upgrades | n/a | n/a | Jan 8, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $156 → $105 | Buy | Maintains | $156 → $105 | +51.52% | Dec 23, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +130.88% | Nov 6, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $160 → $156 | Buy | Maintains | $160 → $156 | +125.11% | Oct 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $160 | Buy | Reiterates | $160 | +130.88% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
355.96B
from 290.40B
Increased by 22.57%
Revenue Next Year
416.52B
from 355.96B
Increased by 17.01%
EPS This Year
27.79
from 22.63
Increased by 22.79%
EPS Next Year
34.30
from 27.79
Increased by 23.45%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 382.8B | 479.4B | 571.0B | ||
| Avg | 356.0B | 416.5B | 460.3B | ||
| Low | 334.3B | 381.0B | 394.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.8% | 34.7% | 37.1% | ||
| Avg | 22.6% | 17.0% | 10.5% | ||
| Low | 15.1% | 7.0% | -5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 32.01 | 40.53 | 51.35 | ||
| Avg | 27.79 | 34.30 | 38.45 | ||
| Low | 25.43 | 29.55 | 31.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 41.5% | 45.9% | 49.7% | ||
| Avg | 22.8% | 23.4% | 12.1% | ||
| Low | 12.4% | 6.3% | -8.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.